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Concurrent prophylactic placement of inferior
vena cava filter in gastric bypass and adjustable
banding operations in the Bariatric Outcomes
Longitudinal Database
Wei Li, MD, MPH,a,b Piotr Gorecki, MD,a Elie Semaan, MD,a William Briggs, PhD,a
Anthony J. Tortolani, MD,a and Marcus D’Ayala, MD,a Brooklyn, NY; and Pittsburgh, Pa
Introduction: Postoperative pulmonary embolism (PE) is a leading cause of morbidity and mortality after bariatric
surgery. However, the concurrent prophylactic placement of an inferior vena cava filter (CPIVCF) in patients undergoing
bariatric operations remains controversial. This study used the Bariatric Outcomes Longitudinal Database (BOLD) to
establish associated characters and determine outcomes of CPIVCF for patients undergoing Roux-en-Y gastric bypass
(GB) and adjustable gastric banding (AB) surgeries.
Methods:We analyzed BOLD, a database of bariatric surgery patient information. GB and AB operations were categorized
into open and laparoscopic approaches. Univariate logistic regressions were used to compare between non-CPIVCF and
concurrent CPIVCF groups. Significant variables (P< .05) were subsequently input into multivariate regression models:
CPIVCF was retained in each model.
Results: A total of 322 CPIVCFs (0.33%) were identified from 97,218 GB and AB operations performed between 2007
and 2010 in this retrospective registry study. Significant differences were identified in male gender (21.1% vs 31.4%; P<
.001), preoperative body mass index (BMI; 44.5  6.6 vs 45.3  7; P < .001), and African-American race (10.5% vs
18%; P < .001) between non-CPIVCF and CPIVCF groups. The CPIVCF group had more patients with previous
nonbariatric surgery (50% vs 43.6%; P  .02), a history of venous thromboembolism (VTE; 21.4% vs 3.1%; P < .001),
impairment of functional status (7.8% vs 3.1%; P < .001), lower extremity edema (47.2% vs 27.1%; P < .001), obesity
hypoventilation syndrome (7.1% vs 2.1%; P < .001), obstructive sleep apnea syndrome (58.1% vs 43.3%; P < .001), and
pulmonary hypertension (13% vs 4.1%; P < .001). Patients in the CPIVCF group were more likely to receive GB than
gastric banding (77% vs 58.1%; P < .001) and an open surgical approach (21.4% vs 4.8%; P < .001). Operative duration
was longer in the CPIVCF group (119 67 vs 89 52 minutes; P< .001). The CPIVCF group also had a longer length of
hospital stay (3 2 vs 2 6 days; P .048), was associated with higher incidence of deep venous thrombosis (DVT; 0.93%
vs 0.12%;P< .001), and had a higher mortality (0.31% vs 0.03%;P .003) from PE and indeterminate causes. In multivariate
analysis, male gender, African-American race, previous nonbariatric surgery, a high BMI, obesity hypoventilation syndrome,
history of VTE, lower extremity edema, and pulmonary hypertension were preoperative factors associated with CPIVCF.
Conclusions: CPIVCF was associated with specific clinical features, increased health care resource utilization, and a higher
mortality in patients undergoing bariatric operations. Although selected patient characteristics influence surgeons to
perform CPIVCF, this study was unable to establish an outcome benefit for CPIVCF. (J Vasc Surg 2012;55:1690-5.)
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VObesity is reaching epidemic proportions and is quickly
becoming a major public health concern. In fact, a recent
report found that the obesity rate in the United States has
more than doubled over the past 4 decades and that over
30% of American adults are defined as obese by having a
body mass index (BMI)30 kg/m2.1 Conventional meth-
ods of weight loss, such as diet and exercise, are less
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1690ffective than bariatric surgery in the obese population and
growing body of evidence now favors bariatric surgery for
he treatment of morbid obesity.2 This has led to a fivefold
ncrease in the utilization rate of bariatric surgery.3 Bariatric
urgical procedures, such as the Roux-en-Y gastric bypass
GB) and adjustable gastric banding (AB), not only achieve
urable weight loss but also prolong life and significantly
ecrease obesity-related comorbidities such as type 2 dia-
etes, hyperlipidemia, hypertension, and obstructive sleep
pnea.4,5 However, bariatric surgery is not without risk,
nd venous thromboembolism (VTE) represents one of the
eading causes of postoperative morbidity and mortality.3,6
Bariatric patients are generally considered to be a group
t high risk for postoperative VTE.7,8 Obesity is a well
ecognized independent risk factor for VTE, particularly
hen these patients are hospitalized for surgical proce-
ures.7,9 Additionally, bariatric patients often have other
isk factors that can increase the incidence of postoperative
TE, a complication which has been reported in up to 4%
f patients undergoing bariatric surgery despite adequate
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Volume 55, Number 6 Li et al 1691prophylaxis.8,10,11 Although VTE prophylaxis is routinely
used, the optimal means of VTE prophylaxis is not well
established and the benefit of prophylactic placement of
inferior vena cava filter (PPOIVCF) remains unclear. Sev-
eral authors have suggested PPOIVCF in select bariatric
surgery patients at high risk for VTE.12-14 However, there
is no clear benefit associated with IVC filter placement or
any prospective, randomized data available to evaluate the
efficacy of IVC filters for the prophylaxis of pulmonary
embolism (PE) in bariatric surgery patients.9,15
The purpose of this study was to determine the
associated characteristics and outcomes for the concur-
rent prophylactic placement of inferior vena cava filters
(CPIVCFs) in patients undergoing GB and AB surgeries
using the Bariatric Outcomes Longitudinal Database
(BOLD). Managed and audited by the Surgical Review
Corporation (SRC), BOLD is a large, prospective registry
of bariatric surgery information collected for all patients
undergoing bariatric surgery at centers participating in the
Bariatric Surgery Center of Excellence (BSCOE) pro-
gram.7,16 BOLD contains 324,528 patient records as of
November 2010, with an average accrual rate of 12,000
patients per month. These data are currently entered into
BOLD by more than 1000 surgeons and 600 facilities.7
METHODS
This study used BOLD and was approved by the
SRC, who granted data access under the BOLD Data
Dissemination Agreement in October of 2010. BOLD
was created by the SRC in 2007 to monitor and track the
outcomes of surgeries performed by participants in the
American Society for Metabolic and Bariatric Surgery
BSCOE program. BSCOE participants are required to
enter prospective data for all bariatric surgery patients
during all phases of care, including data collected at the
preoperative visits, during the hospital stay, and at the
postoperative visits. BOLD is registered with the Na-
tional Institutes of Health (NCT01002352; available
from http://www.clinicaltrials.gov).7
Our study population consisted of patients who re-
ceived GB and AB operations. These two groups were
further subcategorized by surgical approach, either open or
laparoscopic. The present study included only those pa-
tients who had undergone GB or AB surgery from 2007 to
2009 and for whom 90-day postoperative follow-up visit
information was available. This population was used to
identify all the patients with or without CPIVCFs. A de-
scription of the patient data entered into BOLD and avail-
able for this study has been previously reported by the
SRC.7,16,17
Statistical analysis. Statistical analysis was performed
using the R Project for statistical computing (http://www.
r-project.org/). Three separate outcomes were judged to
be of interest: death from pulmonary embolus or indeter-
minate death, presence of postoperative PE, and presence
of postoperative deep venous thrombosis (DVT).
A large list of possible predictive variables was gathered
from the BOLD database. These included demographic uariables, medical history variables, and surgical parame-
ers. Given an outcome, each variable was used as an
ndependent variable in a logistic regression model. Vari-
bles which were classed as statistically significant, with a
est level set at 0.05, were collected into a multivariate
orward-backward stepwise logistic regression model to
inimize the Akaike Information Criterion. This proce-
ure automatically eliminated variables that were not sig-
ificant. However, the variable indicating the presence of
he IVC filter was kept in all models. After the stepwise
odel converged, the variable indicating presence of the
VC filter was then checked for its interaction effects with
ach other independent variable. No interactions were
ound. We report the odds ratios and 95% confidence
ntervals for each independent variable on the final models.
ESULTS
From 2007 to 2009, BOLD included 97,218 patients
ho underwent GB or AB bariatric procedures with full
0-day postoperative follow-up visit information, with this
eing our study group. Of these patients, 51,827 (53.36%)
nderwent laparoscopic Roux-en-Y GB, 4649 patients
4.79%) open Roux-en-Y GB, 40,612 patients (41.81%)
aparoscopic gastric band placement, and 40 patients
0.04%) underwent open gastric band placement (Table I,
). With subgroup analysis, laparoscopic Roux-en-Y GB
roup received the majority (77.02%) of CPIVCF (Table I,
and C).
Of the entire study group, only 322 (0.33%) patients
able I. A, Distribution of study groups
Laparoscopic (%) Open (%) Total (%)
djustable
banding
40,612 (41.81) 40 (0.04) 40,652 (41.85)
astric bypass 51,827 (53.36) 4649 (4.79) 56,476 (58.15)
otal 92,439 (95.17) 4689 (4.83) 97,128 (100)
able I. B, Distribution of study groups of patients
ithout CPIVCF
Laparoscopic (%) Open (%) Total (%)
djustable
banding
40,538 (41.88) 40 (0.04) 40,578 (41.92)
astric bypass 51,648 (53.35) 4580 (4.73) 56,228 (58.08)
otal 92,186 (95.23) 4620 (4.77) 96,806
PIVCF, Concurrent prophylactic placement of inferior vena cava filter.
able I. C, Distribution of study groups of patients with
PIVCF
Laparoscopic (%) Open (%) Total (%)
djustable banding 74 (22.98) 0 (0) 74 (22.98)
astric bypass 179 (55.59) 69 (21.43) 248 (77.02)
otal 253 (78.57) 69 322 (100.00)
PIVCF, Concurrent prophylactic placement of inferior vena cava filter.ndergoing CPIVCF were identified, with the non-
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June 20121692 Li et alCPIVCF group consisting of 96,806 patients. Significant
differences in demographic and preoperative variables
were seen between the CPIVCF and non-CPIVCF
groups. Patients in both groups were more likely women
and in the fifth decade of life, but there was a larger
number of men in the CPIVCF group. The patients in
the CPIVCF group also had a higher BMI and were more
likely to be of African-American race than those in the
non-CPIVCF group. Additionally, the CPIVCF group
had more patients with previous nonbariatric surgery, a
history of VTE, impairment of functional status, lower
extremity edema, obesity hypoventilation syndrome, and
pulmonary hypertension (Table II).
Intraoperatively, patients in the CPIVCF group were
more likely to receive GB than gastric banding and
undergo an open surgical approach. Operative duration
was longer for the patients in the CPIVCF group but
there was no difference in the need for blood transfusion.
When compared to the non-CPIVCF group, patients in
CPIVCF group were more likely to receive intraopera-
tive anticoagulation and foot pump as means for DVT
prophylaxis. The CPIVCF group was also more likely to be
clustered with central venous catheter placement, cholecys-
tectomy, hiatal hernia repair, and umbilical hernia repair
(Table III). When analyzing clinical outcomes, the
CPIVCF group had a longer length of hospital stay, a
higher incidence of postoperative DVT, and a higher mor-
tality from PE and indeterminate causes than the non-
CPIVCF group (Table IV).
Inmultivariate analysis, male gender, African-American
race, previous nonbariatric surgery, a high BMI, obesity
Table II. Demographic and admission variables between
comparison groups
Variables
Non-CPIVCF
n  96,806
CPIVCF
n  322 P value
Age 46  12 47  13 .1
Male gender, % 21.1 31.4 .001
Preoperative BMI (kg/m2) 44.5  6.6 45.3  7.0 .001
Race
African American, % 10.5 18 .001
Comorbidities, %
DVT/PE, % 3.1 21.4 .001
Impairment of functional
status, %
3.1 7.8 .001
Lower extremity edema, % 27.1 47.2 .001
Obesity hypoventilation
syndrome, %
2.1 7.1 .001
Pulmonary hypertension, % 4.1 13 .001
Previous surgery
Previous nonbariatric
surgery, %
43.6 50 .02
BMI, Body mass index; CPIVCF, concurrent prophylactic placement of an
inferior vena cava filter; DVT, deep vein thrombosis; Non-CPIVCF, non-
concurrent prophylactic placement of an inferior vena cava filter; PE, pul-
monary embolism.
Continuous variables reported as means ( SD) and categorical variables as
percentage of patients.hypoventilation syndrome, history of DVT or PE, lower bxtremity edema, pulmonary hypertension, concurrent
entral venous catheter placement, utilization of anticoag-
lation and foot pump for DVT prophylaxis, and open
urgical approach were preoperative factors associated with
PIVCF (Table V).
ISCUSSION
Bariatric surgery is currently the most effective treat-
ent available for patients with morbid obesity and is
ncreasingly used in the United States, a trend that is
ikely to continue.1,3,18 Although the use of GB has been
he primary driving force in this trend, laparoscopic AB is
aining popularity.18,19 In our study cohort, laparo-
copic AB represents a significant number (41.81%) of
he total bariatric operations. Compared to GB, AB has a
egligible rate (0.04%) of conversion to an open proce-
ure and a lower incidence of VTE.
VTE is somewhat surprisingly an unlikely event after
able III. Intraoperative measurements between
omparison groups
ariables
Non-CPIVCF
n  96,806
CPIVCF
n  322
P
value
VT prophylaxis method
Anticoagulation, % 80.6 89.8 .001
Foot pump, % 8.5 15.5 .001
Bariatric procedure performed:
gastric bypass vs adjustable
banding, %
58.1 77 .001
Surgical approach: open vs
laparoscopic, %
4.8 21.4 .001
Surgery duration, minutes 89  52 119  67.001
oncurrent surgical procedures
Central venous catheter
placement, %
1.1 6.8 .001
Cholecystectomy, % 3.2 9.6 .001
Hiatal hernia repair, % 12.2 5.6 .001
Umbilical hernia repair, % 1.4 3.1 .01
PIVCF, Concurrent prophylactic placement of an inferior vena cava filter;
VT, deep vein thrombosis; Non-CPIVCF, nonconcurrent prophylactic
lacement of an inferior vena cava filter.
ontinuous variables reported as means ( SD) and categorical variables as
ercentage of patients.
able IV. Outcome and postoperative complications
etween comparison groups
ariables
Non-CPIVCF
n  96,806
CPIVCF
n  322 P value
ength of stay (days) 2  6 3  2 .048
VT, % 0.12 0.93 .001
E, % 0.12 0.31 .33
eaths from PE or
indeterminate causes, %
0.03 0.31 .003
PIVCF, Concurrent prophylactic placement of an inferior vena cava filter;
VT, deep vein thrombosis; Non-CPIVCF, nonconcurrent prophylactic
lacement of an inferior vena cava filter; PE, pulmonary embolism.
ontinuous variables reported as means ( SD) and categorical variables as
ercentage of patients.ariatric surgery. Previous studies have documented that
d
a
p
c
r
p
g
p
i
e
w
l
l
I
r
t
t
e
w
p
d
s
e
C
t
A
a
c
w
o
c
s
c
i
o
t
C
s
i
d
a
p
s
s
b
s
m
s
t
t
v
s
S
a
JOURNAL OF VASCULAR SURGERY
Volume 55, Number 6 Li et al 1693the postoperative VTE rates of bariatric surgeries are low
and commonly reported at much under 1%.8,10,11,20 Al-
though PE after bariatric surgery is rare, it represents one of
the leading causes of postoperative death in this patient
population. In one study, nearly 40% of all postoperative
deaths after GB procedures were attributed to PE, making
it the second leading cause of death after anastomotic
leak.3,21,22 This figure may still underestimate themortality
of postoperative PE after bariatric surgery, as other studies
have suggested that most deaths from indeterminate causes
are actually as a result of undiagnosed PE.7,21-23
Clinical guidelines have been proposed for VTE pro-
phylaxis in patients undergoing weight loss surgery but
they are not uniformly agreed upon.8,12,13,20,24 In practice,
VTE prophylaxis for such patients ranges from early ambu-
lation and use of lower extremity sequential compression
devices to the use of unfractionated or low-molecular-
weight heparin and PPOIVCF.25-27 However, there are
few studies documenting the outcomes of CPIVCF in
bariatric surgery patients.8,28,29 CPIVCF represents the
most aggressive and invasive approach among all prophy-
lactic maneuvers considered for patients at high risk for
VTE undergoing bariatric surgery and has been recom-
mended for those with a history of DVT or PE, lower
extremity venous disease, poor mobility, BMI50 kg/m2,
and pulmonary hypertension.8,28 However, there are no
data on the relative risk imparted by such factors or on the
incidence of postoperative VTE among bariatric patients,
and the incidence of postoperative VTE even in the pres-
ence of such high-risk features remains quite low.7,17,26
The outcomes of IVC filter placement are largely de-
pendent on patient selection, technique, filter type, use of
Table V. Adjusted OR and 95% CI for predictor
variables of CPIVCF in multivariate regression analysis
Variables Adjusted OR 95% CI P value
Male gender 1.46 1.12-1.89 .004
African-American race 1.54 1.13-2.06 .005
Previous nonbariatric surgery 1.54 1.21-1.95 .001
BMI 1.06 1.05-1.07 .001
Comorbidities
Obesity hypoventilation
syndrome
1.69 1.00-2.72 .04
Previous DVT or PE 6.57 4.91-8.69 .001
Lower extremity edema 1.46 1.15-1.86 .002
Pulmonary hypertension 2.4 1.64-3.43 .001
Anticoagulation (DVT
prophylaxis)
1.79 1.26-2.64 .002
Foot pump (DVT
prophylaxis)
1.79 1.29-2.44 .001
Open surgical approach 3.22 2.35-4.36 .001
Concurrent surgical
procedures
CVCP 3.27 1.95-5.25 .001
BMI, Body mass index; CI, confidence interval; CPIVCF, concurrent pro-
phylactic placement of an inferior vena cava filter; CVCP, central venous
catheter placement; DVT, deep vein thrombosis; OR, odds ratio; PE,
pulmonary embolism.concurrent anticoagulation, and the nature, intensity, and euration of surveillance.8,30 IVC filter placement is gener-
lly considered to be a benign procedure with a low com-
lication rate.8,30,31 However, its association with signifi-
ant cost and long-term complications is increasingly
ecognized.8,32 Additionally, IVC filters are not completely
rotective for PE.24,33 Although there are studies investi-
ating the outcomes of IVC filter placement in the bariatric
atient population, most of these studies are not random-
zed and are underpowered to confirm a significant differ-
nce in the rates of PE and related outcomes with and
ithout prophylactic IVC filters.8,14,28,34 They are also of
imited follow-up in a patient population with a reasonably
ong life expectancy. Whereas the feasibility of retrievable
VC filter placement is well established, the utilization of
etrievable filters should be approached with caution given
he low retrieval rates reported in the literature and poten-
ial for filter-related complications such as migration or
mbolism.8,14,35,36
In our analysis, patients with and without CPIVCF
ere different with regard to numerous characteristics. The
atients in the CPIVCF group tended to have higher
istribution of commonly recognized risk factors for VTE
uch as a higher BMI, history of VTE, lower extremity
dema, and impaired functional status. In addition, the
PIVCF group had more African Americans, male pa-
ients, and patients who had previous nonbariatric surgery.
lthough this study identified multiple intraoperative char-
cters that differed between these two groups, we found no
linical benefit associated with CPIVCF. In fact, CPIVCF
as associated with a longer hospital stay, higher incidence
f DVT, and higher mortality from PE or indeterminate
auses. While we statistically controlled for observed mea-
ures, including comorbidities, open operative approach, or
oncurrent operative procedures, specifically checking the
nteraction of IVC filter status and each other variable in
ur models, it is possible that IVC filter status is an indica-
or or proxy for illness severity.
This study represents a retrospective analysis of
PIVCF using BOLD. Our study is retrospective and
ubject to the errors generally associated with retrieving
nformation from such a large administrative database. The
ata we analyzed were self-input by BSCOE participants
nd associated with inherent limitations. One completed
atient record in BOLDmay represent the contributions of
everal hospital staff members from different hospital divi-
ions. Commonly recognized in any administrative data-
ase, this data vetting process is subject to entry errors and
election and reporting bias.
Almost all reported studies about prophylactic place-
ent of IVC filters in bariatric surgery were based on case
eries from a single institution or a group of institu-
ions.9,13,24,25,33,37 Conversely, our study analyzed BOLD,
he largest prospective longitudinal database available and a
ery well maintained comprehensive repository of bariatric
urgery patient information from centers across the United
tates.7,16,17 However, a common criticism of such large
dministrative data resources is lack of specificity.38-40 For
xample, BOLD does not elucidate information regarding
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June 20121694 Li et althe specific type of IVC filter inserted, nor does it provide
data regarding IVC filters placed before bariatric surgery.
Also, BOLD offers no data about specific pharmacologic
agents or dose of anticoagulation used for VTE prophylaxis
or treatment. Although BOLDdoes provide data regarding
previous nonbariatric surgery, specific operations are not
listed and we could not retrieve any information to reveal
previous venous procedures. Another limitation of this
study is that the complications of postoperative VTE and
mortality are rarely seen after bariatric surgery, and there-
fore, a type 2 error is a possible explanation for our findings.
Additionally, we did not include any complications be-
yond the 90-day postoperative period, and this study was
limited to those patients for whom 90-day follow-up
information was complete and who underwent GB or AB
operations. Other patients were excluded and this might
have underestimated the morbidity associated with IVC
filter placement.
In conclusion, our results indicated that CPIVCF was
associated with specific clinical features, increased health
care resource utilization, a higher incidence of postopera-
tive DVT, and a higher mortality in patients undergoing
bariatric operations. This study was therefore unable to
establish an outcome benefit for CPIVCF, which in current
practice remains a rare concurrent procedure in GB and AB
operations.
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